SOURCE: Martin Nutraceuticals Inc.

March 20, 2006 10:44 ET

Research Study Indicates Two Widely Used Supplements for Arthritis Pain Are Found to Be Ineffective

RENO, NV -- (MARKET WIRE) -- March 20, 2006 -- Martin Nutraceuticals Inc. (OTC: MNCL). Two widely used nutritional supplements for arthritis pain do not effectively soothe patients aching knees, a large US study has found.

The study of glucosamine and chondroitin was meant to provide a definite answer to a question that has baffled doctors and patients alike. Do these supplements work?

In the 24 week study published in the New England Journal of Medicine, 1583 patients with osteoarthritis of the knee were randomly assigned to one of five groups. Some patients took glucosamine, some took chondroitin and some took both. Others took a placebo or Celebrex.

No effect was found for glucosamine, chondroitin, or the combination of both.

Between December 2003 and December 2005 Canadians bought $64 million worth of glucosamine or 4.5 million unites according to the marketing information company AC Nielson, while Americans spent an estimated $734 million on glucosamine and chondroitin in 2004 according to the Nutrition Business Journal. The two are often sold in combination as a treatment for arthritis.

Harvey Panesar, President of Martin Nutraceuticals Inc., had this comment, "We are pleased that we are able to supply one of our flagship products, Arthrizyme™ as a proven remedy for the pain and inflammation associated with arthritis. (Read Martin Press Release: March 7, 2006 - Martin Nutraceuticals Inc. (MNCL: OTCPK) references new studies that show the effectiveness of using its’ proprietary product Arthrizyme™). With Arthrizyme™ consumers can now feel confident that they are getting what they are paying for."

Arthrizyme™ is a proprietary blend of systemic enzymes designed to rapidly reduce inflammation associated with arthritis pain. Arthrizyme™, however, is not limited to its anti-inflammatory effect, but also assists the body in the healing process by breaking down fibrin in joints and muscles.

Dr. Anthony Martin, Director of Research at Martin Nutraceuticals Inc. suggests that these results open the door for clinically proven Arthrizyme. "As we prepare to launch Arthrizyme across North American, people will have an alternative to glucosamine and chondroitin. The timing couldn't be better for us as this study proves the window of opportunity is there to tackle a major health problem with Arthrizyme."

About Martin Nutraceuticals Inc.

Martin Nutraceuticals Inc. is a company focused on providing a better health and lifestyle through natural products. Martin Nutraceuticals flagship products include Arthrizyme™ for general joint pain and Oxygenol™ for anti-oxidation and Maximum Slim™ for weight control.

Arthrizyme™ is a unique blend of systemic enzymes designed to rapidly reduce inflammation in joints and muscles. Arthrizyme™ is not limited to anti-inflammatory effects; it also assists the body in the healing process by breaking down fibrin in joints and muscles. Arthrizyme™ differs from all other natural arthritis remedies and was designed to work for all types of arthritis and in all joints of the body. Arthrizyme™ is fast acting, usually improving symptoms within the first few days.

Safe Harbor Statement

This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The risks and uncertainties that may affect the operations, performance development and results of the Company's business include but are not limited to fluctuations in financial results, availability and customer acceptance of our products and services, the impact of competitive products, services and pricing, general market trends and conditions.

Contact Information